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Abstract 
Background. Exposure to secondhand tobacco smoke (SHS) is a well-established risk 
factor for cardiovascular disease and lung cancer in non-smoking adults. However, few 
studies have focused on the health consequences of exposure to SHS in older adults. 
This is the first study to assess the association between SHS and the frailty syndrome in 
the non-smoking older adult population. 
Methods. Cross-sectional study among 2059 non-smoking adults aged ≥60 years who 
participated in the third U.S. National Health and Nutrition Examination Survey and 
had completed a physical examination. Exposure to SHS was assessed by serum 
cotinine concentrations and by self-reported data from the home questionnaire. Frailty 
was ascertained with a slight modification of the Fried criteria. Analyses were 
performed with logistic regression and adjusted for the main confounders. 
Results. The median (interquartile range) concentration of serum cotinine was 0.095 
(IQR: 0.035-0.211) ng/mL. The prevalence of frailty was 6.0%.  The odds ratios (95% 
CI) of frailty comparing the second, third and fourth to the lowest quartile of serum 
cotinine were, respectively, 1.44 (0.67-3.06), 1.46 (0.75-2.85) and 2.51 (1.06-5.95); p 
value for trend 0.04. An increased frequency of frailty was also observed in participants 
reporting to live with ≥2 smokers at home (odds ratio: 5.37; 95% CI: 1.13-25.5).  
Conclusions. In the US non-smoking older adult population, exposure to SHS was 
associated with an increased frequency of frailty. More efforts are needed to protect 
older adults from SHS, especially at home and in other areas not covered by smoke-free 
regulations.  
Key words: Second hand smoke, cotinine, older adults, frailty. 
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INTRODUCTION 
Exposure to secondhand tobacco smoke (SHS) is a well-established risk factor for 
coronary heart disease1, lung cancer1 and stroke2 in non-smoking adults; there is also 
suggestive evidence that SHS could increase the risk of asthma and chronic obstructive 
pulmonary disease.1 Older adults may be very susceptible to the effects of SHS because 
of age-related physiologic changes and coexisting health conditions.3 Moreover, they 
may be at increased risk of involuntary exposure because they spend most time indoors 
and they are at higher risk of functional and economic dependency. Despite this, 
surprisingly, few studies have focused on the health consequences of exposure to SHS 
in older adults.4,5  
Frailty, a potentially preventable geriatric syndrome, is characterized by diminished 
physiologic reserve across multiple organ systems with decreased ability of the old 
individual to cope with environmental stressors.6 Frailty has been linked to increased 
risk for adverse outcomes in older adults, including falls,7 disability,8 
institutionalization9 and death.10,11 Given the high frequency of frailty and its serious 
health and disability consequences, extensive research is being conducted to identify 
preventable risk factors and to understand mechanistic pathways.  
In this study, we evaluated for the first time the association between SHS and frailty in 
the non-smoking older adult population using data from the third US National Health 
and Nutrition Examination Survey (NHANES III). 
METHOD 
Study participants 
NHANES III was a multistage, stratified, clustered probability survey of the US civilian 
non-institutionalized population, conducted between 1988 and 1994 by the National 
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Center for Health Statistics. The survey consisted of a household interview and a 
standardized physical examination performed in a mobile center. We limited our study 
to 3086 adults ≥60 years who reported “having never smoked ≥100 cigarettes during 
their entire life” and had completed the physical examination. To ensure that we did not 
include smokers in the study, we also excluded participants who had serum cotinine 
concentrations above 10 ng/mL (N=993). Furthermore, we excluded 34 individuals with 
missing values in potential confounders (education, body mass index [BMI], 
morbidities or drug treatments), leading to a final analytical sample of 2059 individuals.  
The study protocol was approved by the NHANES Institutional Review Board (IRB), 
and written informed consent was obtained from all participants. 
Study variables 
Secondhand Tobacco Smoke 
Exposure to SHS was assessed by using self-reported data from the home questionnaire 
and serum cotinine, a specific biomarker of tobacco exposure.12 Serum cotinine was 
measured using high performance liquid chromotography/atmospheric pressure 
chemical ionization tandem mass spectrometry. The limit of detection (LOD) for serum 
cotinine using this method was 0.05 ng/mL and values under the LOD were replaced by 
the square root of 2 (0.035 ng/mL). Never smokers who presented serum cotinine 
concentrations ≥0.035 ng/mL or who self-reported living with at least 1 person who 
smoked were considered exposed to SHS.  
Frailty 
Frailty was assessed with a slight modification of the definition developed by Fried and 
colleagues 9 in the Cardiovascular Health Study (CHS). Individuals meeting  ≥3 of the 
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following 5 criteria were considered as frail: 1) Weakness, considered present if the 
individual answered “some difficulty”, “much difficulty” or “unable to do it” to the 
question “How much difficulty you have lifting or carrying something as heavy as 10 
pounds?”; 2) Exhaustion, defined as any of these responses “some difficulty”, “much 
difficulty” or “unable to do it” to the question “How much difficulty do you have 
walking from one room to the other on the same level?”; 3) Low body weight, defined as 
BMI  ≤18 kg/m2; 4) Slow walking speed, defined as the worse quintile in the eight-foot 
walking speed test, adjusted for sex and height13; 5) Low physical activity, considered 
present in individuals who answered “less active” to the question: “When compared to 
most men/women of your age, would you say that you are more active, less active or 
about the same?” 
Potential confounders 
Questionnaire information included sex, age, education, race/ethnicity, presence of 
comorbidities and number of drug treatments used. Participants were asked about their 
previous history of cardiovascular disease (coronary heart disease, stroke congestive 
heart failure), hypertension, diabetes, osteoarticular disease (osteoporosis, rheumatoid 
arthritis and osteoarthritis), respiratory disease (asthma, chronic bronchitis or 
emphysema) and cancer. During the medical examination, blood pressure was measured 
three times with the participant seated for 5 minutes and using an appropriate sized cuff. 
Hypertension was defined as self-reported physician diagnosis of high blood pressure or 
a mean systolic/diastolic blood pressure ≥140/90 mm Hg. Finally, weight and height 
were measured in standardized conditions, and BMI calculated as weight in kg divided 
by squared height in m.  
Statistical analyses  
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The association between SHS exposure and the presence of frailty was evaluated using 
logistic regression. Two sets of models were built, one in which serum cotinine was the 
main independent variable, and one in which exposure to SHS was defined according to 
the number of smokers at home. In the first set of models (table 2), participants were 
classified into quartiles of serum cotinine, with the lowest quartile (individuals with 
cotinine concentrations under the LOD) being the exposure reference. Additionally, ln-
transformed cotinine was modeled as a continuous variable and odds ratios comparing 
the 75th versus the 25th percentiles of its distribution were derived. In the second set of 
models (table 3), participants were classified into three categories of exposure according 
to the number of smokers at home (0, 1, ≥2).  All models were first adjusted for sex and 
age (model 1), and then further adjusted for education, ethnicity, BMI, morbidity and 
number of drug treatments (model 2). Additionally, when the number of smokers at 
home was the main independent variable, a third model (model 3) further adjusting for 
the number of rooms per household was fitted.  
Next, we estimated the association between cotinine concentrations and frequency of 
each frailty criterion (table 4). Again, two main models that accounted for the 
previously defined subsets of covariates were fitted.  
Finally, to graphically evaluate the dose-response association between serum cotinine 
concentrations and frailty, serum cotinine concentrations were separately modeled using 
restricted cubic splines with knots at the 10th (0.035 ng/mL), 50th (0.095 ng/mL) and 90th 
(0.645 ng/mL) percentile of its distribution. In all analyses, we took sample weights and 
NHANES survey design into consideration by using the svy commands in Stata 13. 
RESULTS 
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The mean age of the population was 71.3 years and 74% were women. The median 
(interquartile range) concentration of serum cotinine was 0.095 (IQR: 0.035-0.211) 
ng/mL. Around 10% of the population lived with at least one smoker. Compared to 
individuals whose serum cotinine concentration was undetectable, those with detectable 
cotinine concentrations were more likely to be men, had lower age, lower medicine 
consumption, were more likely to be non-Hispanic black, and had lower education and 
greater BMI (table 1). Additionally, never-smokers living with ≥1 smokers at home 
showed higher serum cotinine concentrations. 
Among the study participants, 166 (6.0%) were frail. Frailty was more common among 
women, those ≥74 years of age, non-Hispanic white and Mexican-American 
participants, and those with lower education. After multivariate adjustment, the odds 
ratio (95% confidence interval [CI] of frailty comparing the second, third and fourth 
quartiles of serum cotinine to the lowest quartile were, respectively, 1.44 (0.67-3.06), 
1.46 (0.75-2.85) and 2.51 (1.06-5.95); p value for trend 0.04 (table 2). In spline 
regression models (figure 1), the dose-response relationship was progressive over the 
range of serum cotinine concentrations (p value for the nonlinear component=0.11).  
An increased frequency of frailty was also observed in participants living with smokers 
at home. Compared to those who do not live with smokers, the odds ratio (95% CI) of 
frailty for those living with 1 or ≥2 smokers were, respectively, 1.46 (0.67-3.20) and 
6.82 (1.83-25.4); p value for trend <0.01 (table 3). Results were similar after further 
adjustment for the number of rooms per household: 1.40 (0.58-3.41), 5.37 (1.13-25.5), p 
value for trend 0.04. 
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Table 4 shows the association between serum cotinine and the five components of the 
frailty syndrome. Higher serum cotinine was associated with higher frequency of 
weakness and with, a marginally significant, increased frequency of exhaustion. 
DISCUSSION 
In this sample of non-smoking older adults from the US general population, exposure to 
SHS, as measured using serum cotinine concentrations and self-reported information on 
the number of smokers at home, was associated with an increased prevalence of frailty.  
The association was independent of potential confounders such as sex, age, education, 
ethnicity, BMI, drug treatments or previous history of cardiovascular disease 
hypertension, diabetes, osteoarticular disease, chronic respiratory disease and cancer. 
Worldwide, around 33% of male and 35% of female non-smoking adults were exposed 
to SHS in 2004.14 Since then, many nations have passed bans on smoking in public 
spaces, but still millions of nonsmokers continue to be exposed to SHS in areas not 
covered by smoke-free regulations, including homes.15  In the US only, around 14 
million of the non-institutionalized, non-smoking adults aged ≥60 years were exposed to 
SHS during 2007-200815.  Moreover, according to the last Tobacco Use Supplement to 
the Current Population Survey, fewer than half of households with smokers in the US 
have adopted smoke free home rules16. Because a high proportion of adults ≥60 years 
reside in nursing homes and most countries have no laws regulating smoking in these 
settings, the magnitude of SHS exposure among older adults is likely to be greater. 
Some studies have shown that active smoking can induce muscular damage and  
sarcopenia in the old age.17 In line with this finding, results from the Hallym Aging 
Study indicated that smoking was associated with higher frequency of decreased grip 
strength in men aged ≥65 years.18 In cross-sectional analyses, current smoking19 and 
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consumption of ≥ 1 pack/day of cigarettes for ≥ 20 years20 have been linked with an 
increased prevalence of frailty indicators, while some prospective cohort studies have 
shown that baseline smoking status is a strong predictor of frailty 21-23 and disability.24-27 
Since this is the first study to evaluate the association between SHS and frailty, we 
cannot compare our results with previous findings. However, there is evidence that SHS 
increases the risk of several diseases that are linked to frailty, including coronary heart 
disease, stroke and lung cancer.1,2 Some studies have also linked SHS exposure in older 
adults with the risk of dementia28,29,30, cognitive impairment,31-33 ,  and  worse scores in 
the mental health dimension of the SF-36 34. Among never-smokers, high lifetime SHS 
exposure at home has been associated with decreased mineral density in both adult men 
and women,35 and with increased risk of osteoporosis in postmenopausal women.36 
Finally, in a cross-sectional study based on NHANES 1999-2002, authors found that 
SHS exposure among nonsmoking older adults was associated with reduced physical 
function and reduced gait speed.32 Interestingly, in our study the association with 
reduced physical function and reduced gait speed was not statistically significant, 
suggesting that SHS-related frailty was mainly driven through the high frequency of 
weakness and exhaustion.  
This study has several strengths. First, it includes a large sample representative of the 
US general population aged ≥ 60 years. Second, the availability of serum cotinine, a 
specific biomarker of tobacco smoke exposure, reduces the possibility of exposure 
misclassification and allows for evaluating the dose-response relationship between SHS 
and frailty. And third, the study accounted for numerous covariates, so that residual 
confounding is likely to be small.  
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Some limitations of this study should also be acknowledged. First, the lack of 
prospective information limits reaching firm conclusions on SHS as a risk factor for 
frailty. Second, because the sample did not include institutionalized individuals, results 
cannot not be inferred to this population group. Third, we could not account for 
differences in cotinine metabolism. Because nicotine is primarily inactivated to cotinine 
by the hepatic enzyme CYP2A6, variations in its activity can modify serum cotinine 
concentrations. Similarly, there is some evidence that vegetarians and persons with 
higher intake of certain foods (i.e. almonds, broccoli or garlic) may have falsely high 
levels of cotinine. However, we are not aware of reasons why the frequency of slower 
vs. faster nicotine metabolizers, or of those with high vs. low intake of these specific 
foods, could vary with frailty status. Finally, although cotinine levels correctly assess 
recent exposure to secondhand smoke, they may not reflect long term exposure and 
especially past exposure. However, there is evidence that passive smoking is capable of 
precipitating acute changes in several physiological processes that are central to the 
pathogenesis of frailty. Specifically, short-term SHS exposure has been associated with 
increased circulating markers of inflammation (i.e. IL4, IL6 or TNF-α)37-40; changes in 
the immune response with increased white blood, lymphocyte and granulocyte counts41; 
and elevated levels of markers of endothelial disfunction.42 Additionally, previous 
research has found that serum cotinine among never-smokers is associated with 
biomarkers of oxidative stress (i.e. 8-dihydro-2´deoxyguanosine43) and with markers of 
activation of inflammatory and coagulative processes (i.e homocysteine,44,45 
fibrinogen,39,45 factor VIII 39), that are known to be elevated in frail individuals.46-48  
Conclusions 
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In the US non-smoking older adult population, exposure to SHS was associated with an 
increased frequency of frailty. More efforts are needed to protect older adults from SHS, 
especially at home and in other areas not covered by smoke-free regulations.  
 
 
Figure title: Odds ratios (95% confidence intervals) of frailty according to serum 
cotinine concentrations based on restricted cubic splines with knots at the 10th, 50th and 
90th of its distribution. Figure legend: The reference value is set at the 10th percentile of 
cotinine distribution. Odds ratios are adjusted for education, race/ethnicity, BMI, 
cardiovascular disease, hypertension, diabetes, osteoarticular disease, chronic 
respiratory disease, cancer, and number of drug treatments. Lines represent the Odds 
ratio (thick line) and 95% confidence interval (dotted lines), and vertical bars represent 
the histogram of cotinine distribution. Data correspond to the US non-smoking older 
population. 
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